Medpace Holdings, Inc. (MEDP) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Earnings Reports
-
Medpace (MEDP) Q2 2026: Net Bookings Jump 28% as Oncology Mix Reclaims Pipeline
July 24, 2026
-
Medpace (MEDP) Q4 2025: Backlog Cancellations Hit 1-Year High, Margin Pressures Mount as Metabolic Mix Shifts
June 15, 2026
-
MedPace (MEDP) Q1 2026: Cancellations Drive Book-to-Bill Down to 0.88, Clouding Growth Trajectory
April 23, 2026
-
Medpace (MEDP) Q3 2025: Pre-Backlog Surges 30%, Locking in Revenue Visibility for 2026
October 23, 2025
-
MedPace (MEDP) Q2 2025: Backlog Conversion Hits 21% as Cancellations Plunge, Fueling Revenue Acceleration
July 23, 2025
-
MedPace (MEDP) Q1 2025: Book-to-Bill Falls to 0.90 as Cancellations Tighten Backlog Visibility
July 07, 2025